The number of people in hospital with flu remains at a record level for this time of year.
An artificial intelligence (AI) model created by integrating clinical, molecular, and histopathological data significantly ...
IMA203CD8 is a second-generation PRAME cell therapy with enhanced pharmacology in ongoing Phase 1a dose escalationManageable ...
Cervical cancer is the fourth most common cancer for women in the world, with more than 660,000 new cases and nearly 350,000 ...
An artificial intelligence (AI) model created by integrating clinical, molecular, and histopathological data significantly ...
Akeso, Inc. (9926.HK) (Akeso or the Company) announced the presentation of a Phase II clinical study that included a ...
OSE Immunotherapeutics SA ( ORPOF) Discusses Strategic Plan With Four Opportunities for Value Creation December 10, 2025 12:00 PM EST ...
Objectives Delays in cancer diagnosis for patients with non-specific symptoms (NSSs) lead to poorer outcomes. Rapid ...
dA new article published in the Journal of Dental Research explores the development of an integrated data-cleaning and ...
Immix Biopharma is advancing NXC-201, showing 95% complete/near-complete response rates and superior safety. Learn why IMMX ...
A sperm donor with a rare genetic mutation linked to an increased risk of developing cancer fathered at least 197 children across Europe, some of whom have already died from the disease, according to ...